MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ATRC — AtriCure, Inc.
NasdaqAtriCure, Inc.
$55.14
+1.55(+2.89%)
- O
- 52.51
- H
- 55.25
- L
- 52.00
- V
- 1.62M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ATRC
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateAug 5, 2005
Employees1,350
Stock ExchangeNasdaq
Ticker SymbolATRC
Websitehttps://www.atricure.com
Key Financial Statistics
| Market Cap | $2.97B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $25.36 - $61.70 |
| 52-Week Avg Volume | 791.0K |
| VWAP | $54.19 |
| Transactions | 23,308 |
| Total Recorded Bars | 5,324 days |